Can cannabis succeed where other compounds have failedUse of a novel semi-fluorinated alkane drug delivery technology as a vehicle to deliver cannabinoids to the ocular surface reached target tissues without systemic side effects in preclinical studies.
State medical marijuana laws continue to expandMedical marijuana’s therapeutic evidence base remains nascent and controversial but the regulatory landscape is evolving rapidly.
Cannabinoid-based drug pipeline shows promise
Cannabinoid-based drug pipeline shows promiseNew treatment indications are under investigation for the use of cannabinoid-based drugs.
Cannabinoid-based drug pipeline grows: 4 ways to prepareNew treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready?
How marijuana promoters bypass the law — and the public goodIf you think legalization of marijuana is such a good thing, take a look at what's been going on in Colorado.
Top 6 new facts on drug overdosesDeaths from drug overdoses are the leading cause of injury death in the United States, ahead of deaths linked to motor vehicles and firearms, according to the new 2015 National Drug Threat Assessment (NDTA), released by the Drug Enforcement Administration.
Marijuana’s role in optometry and beyondBob Prouty, OD, FAAO, educated a packed house at the American Optometirc Association’s Optometry’s Meeting on marijuana’s use in and outside of eye care.
Cannabinoids: medical perils and benefits
Cannabinoids: medical perils and benefitsDuring the American Academy of Optometry's Academy 2014, panelists outlined the promise and potential pitfalls of cannabinoid-based therapies.
4 drug categories to know to better manage itchSelecting the appropriate drug category is important to effectively manage itch, Sarina Elmariah, M.D., Ph.D., told attendees at the 72nd Annual Meeting of the American Academy of Dermatology.